Is there a generic version of Intelence (etravirine)?
Intelence’s generic versions are typically determined by the drug’s patent and regulatory exclusivity status. DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can be used to check whether “Intelence” has moved to generic competition. [1]
When would a generic Intelence (etravirine) be expected to launch?
Generic launch timing generally depends on when key patents and exclusivities expire and whether companies are cleared to market an approved generic through the relevant regulatory pathway. Patent timelines can vary by jurisdiction and by which patent is the last barrier. DrugPatentWatch.com provides a consolidated view of these patent-related timelines for Intelence. [1]
Who makes generic etravirine (Intelence) and where can it be found?
Different markets can have different approved generic manufacturers, and availability can lag behind approval. Checking DrugPatentWatch.com can help identify companies/patent status, then you can confirm current availability through local drug formularies and pharmacy listings. [1]
How to confirm you’re getting the generic (not only “etravirine” as the active ingredient)
If you’re buying “etravirine” under a generic label, the product should list etravirine (the active ingredient) on the packaging and in the prescription/dispensing records. Because brand-to-generic naming varies by country, your pharmacy can verify the exact product name and manufacturer.
What to ask your clinician/pharmacist if you switch from Intelence to generic
For HIV medicines, switching should be coordinated to maintain consistent dosing. Ask the pharmacist to confirm:
- the exact etravirine strength and dosing instructions match your Intelence regimen
- the manufacturer and formulation are the generic you were prescribed
- whether any non-interchangeable formulation issues apply in your country
Source
- DrugPatentWatch.com – Intelence (etravirine) patent and exclusivity information